                               NIH Public Access
                               Author Manuscript
                               Circulation. Author manuscript; available PMC 2014 April 28.
                           Published final edited form 
NIH-PA Author Manuscript




                            Circulation. 2009 November 10; 120(19): 1883â€“1892. doi:10.1161/CIRCULATIONAHA.108.837724.



                           Glycome Transcriptome Regulation Vasculogenesis
                           Rania Harfouche, PhD#, Dirk M. Hentschel, MD#, Stephanie Piecewicz, BS#, Sudipta Basu,
                           PhD, Cristin Print, MBChB, PhD, David Eavarone, BS, Tanyel Kiziltepe, PhD, Ram
                           Sasisekharan, PhD, Shiladitya Sengupta, PhD
                           Department Medicine (R.H., D.M.H., S.P., S.B., S.S.), Brigham Women's Hospital, Boston,
                           Mass; Department Molecular Medicine Pathology (C.P.), University Auckland, Auckland,
                           New Zealand; Department Biological Engineering (D.E., T.K., R.S.), Massachusetts Institute                            Technology, Cambridge, Mass; Harvard-MIT Division Health Sciences Technology
                           (R.H., S.P., S.B., D.E., T.K., R.S., S.S.), Cambridge, Mass.
                           #   authors contributed equally work.
NIH-PA Author Manuscript




                           Abstract
                                 Backgroundâ€”Therapeutic vasculogenesis emerging concept potentially                                  harnessed management ischemic pathologies. present study elucidates potential
                                 coregulation vasculogenesis heparan sulfate glycosaminoglycanâ€“rich cell-surface
                                 glycome transcriptome.

                                 Methods Resultsâ€”Differentiation embryonic stem cells endothelial cells                                  vitro embryoid body paralleled amplification heparan sulfate glycosaminoglycan
                                 sulfation, correlates levels enzyme N-deacetylase/N-sulfotransferase 1
                                 (NDST1). Small hairpin RNAâ€“mediated knockdown NDST1 modification heparan sulfate
                                 glycosaminoglycans embryonic stem cells heparinases sodium chlorate inhibited
                                 differentiation embryonic stem cells endothelial cells. translated vivo
                                 zebrafish embryo model, genetic knockdown NDST1 resulted impaired
                                 vascularization characterized concentration-dependent decrease intersegmental vessel
                                 lumen large tail-vessel configuration, rescued use exogenous sulfated
NIH-PA Author Manuscript




                                 heparan sulfate glycosaminoglycans. explore cross talk glycome                                  transcriptome vasculogenesis, identified microarray validated wild-type
                                 NDST1 knockdownâ€“associated gene-expression patterns zebrafish embryos. Temporal
                                 analysis 3 developmental stages critical vasculogenesis revealed cascade pathways                                  mediate glycocalyx regulation vasculogenesis. pathways intimately connected
                                 cell signaling, cell survival, cell fate determination. Specifically, demonstrated                                  forkhead box O3A/5 proteins insulin-like growth factor key downstream signals                                  process.



                           Â© 2009 American Heart Association, 
                           Correspondence Dirk M. Hentschel Shiladitya Sengupta, Room 317, 65 Landsdowne St, Cambridge, MA 02139.
                           shiladit@mit.edu dhentschel@partners.org.
                           online Data Supplement available article http://circ.ahajournals.org/cgi/content CIRCULATIONAHA.
                           108.837724/DC1. Guest Editor article Daniel  Simon, MD.
                           Disclosures
                           Harfouche et al.                                                                                             Page 2


                                    Conclusions present study time implicates interplay glycome                                     transcriptome vasculogenesis, revealing possibility harnessing specific cellular
                                    glyco-microenvironments therapeutic vascularization.
NIH-PA Author Manuscript




                              Keywords
                                    neovascularization; physiological; embryonic stem cells; zebrafish; vasculature; signal
                                    transduction; IGF-2

                                              Promotion neovasculature holds potential ameliorating coronary artery disease,
                                              leading cause morbidity mortality United States.1                                               focus inhibiting angiogenesis tumors, therapeutic angiogenesis emerging                                               exciting frontier cardiovascular medicine, recently articulated Ferrara                                               Kerbel.2  physiological revascularization essential embryogenesis tissue
                                              regeneration, occurs wound healing, ischemia,                                               tissue transplantation.

                                              formation neovasculature proceeds 2 distinct processes: vasculogenesis,                                               development primordial vasculature novo, angiogenesis, development NIH-PA Author Manuscript




                                              vasculature existing network.3 prevalent dogma neovasculature                                               adult established primarily process angiogenesis;  recent studies
                                              demonstrated endothelial progenitor cells promote neovascularization,4
                                              presents paradigm vasculogenesis contributes therapeutic
                                              neovascularization adult. example, Transplantation Progenitor Cells                                               Regeneration Enhancement Acute Myocardial Infarction (TOPCARE-AMI) trial
                                              indicated circulating endothelial progenitor cells improve left ventricular ejection
                                              fraction patients myocardial infarction improving neovascularization.5 Recent
                                              studies demonstrated embryonic stem cells (ES cells) differentiate                                               functional endothelial cells (ES-ECs) vasculogenesis process.6,7
                                              Bioluminescence imaging showed longitudinal survival transplanted ES-ECs,                                               echocardiography demonstrated functional improvement arose increased
                                              neovascularization.8 harnessing vasculogenesis potential revolutionize
                                              regenerative medicine contingent means regulate cellular differentiation.

                                              molecular mechanisms underlying vasculogenesis increasingly NIH-PA Author Manuscript




                                              elucidated, limited knowledge exists role cellular glyco-microenvironment                                               process.  angiogenic factors fibroblast growth factor-2 vascular
                                              endothelial growth factor shown bind heparan sulfate glycosaminoglycans
                                              (HSGAGs), key component glyco-microenvironment.9,10 Similarly, recent
                                              study, decreased N-sulfation HSGAG chains reduce platelet-derived growth
                                              factor-BBâ€“induced pericyte recruitment vascular development.11 present
                                              study, focused elucidating cross talk HSGAGs-glycome                                               transcriptome regulating vasculo-genesis, specifically differentiation ES cells                                               endothelium. HSGAGS linear N- O-sulfated biopolymers disaccharide units
                                              covalently linked glycosylphosphatidylinositol-anchored secreted proteins.                                               posttranslationally sulfated Golgi apparatus various glycosynthetic enzymes, 


                                                    Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                          Page 3


                                              N-deacetylase/N-sulfotransferases (NDSTs) rate-limiting. demonstrate                                               expression glycosynthetic enzyme NDST1 sulfation HSGAGs
                                              increase vasculogenesis. Furthermore, pharmacological modulation sulfation
NIH-PA Author Manuscript




                                              pattern knockdown NDST1 blocked vasculogenesis, rescued addition
                                              exogenous HSGAGs. confirmed findings vivo larval zebrafish,                                               downregulation NDST1 resulted impaired vascular development. Finally, identified
                                              downstream pathways mediate regulation vasculogenesis                                               HSGAGs. present study reveals exciting potential harnessing defined cellular
                                              glyco-microenvironments directed differentiation precursor cells adult tissue                                               vitro vivo.


                              Methods
                              Cell Culture
                                              Murine ES cells (129 substrain), obtained ATCC (Manassas, Va), differentiated
                                              leukemia inhibitory factorâ€“negative media seeding cells density 1600 cells/cm2
                                              ultralow attachment conditions promote embryoid body formation. specific
                                              days, equal number cells taken dish subjected real-time
NIH-PA Author Manuscript




                                              polymerase chain reaction (RT-PCR), Western blotting, immunohistochemistry                                               monitor expression endothelial cell markers.

                              Enzymatic Chemical Modification Glycocalyx
                                              ES cell-surface HSGAGs modified treatment 10 mU/mL heparinase 
                                              heparinase III, sodium chlorate. end experiments, cells collected,
                                              washed PBS, analyzed endothelial differentiation RT-PCR, immunoblotting,
                                              immunohistochemistry. HSGAG modification characterized capillary
                                              electrophoresis.

                              Isolation Compositional Analysis ES Cell-Surface HSGAGs
                                              Cells trypsinized 30 minutes 37Â°C harvest cell-surface HSGAGs. Cells                                               counted normalize cell number subsequent capillary electrophoresis analysis.
                                              HSGAGs purified ultrafree DEAE column. Eluted fragments                                               concentrated Centricon filters (molecular weight cutoff 3 kDa; Millipore Corp,
NIH-PA Author Manuscript




                                              Billerica, Mass), freeze-dried overnight, digested 30Â°C incubation 3 mIU
                                              heparinase  II, III. Digested glycosaminoglycan fragments analyzed                                               Agilent 3-dimensional capillary electrophoresis 72-cm extended light path
                                              capillary 75-Î¼m inner diameter (Agilent Technologies, Santa Clara, Calif). Negative
                                              polarity separation monitored 235 nm 50 mmol/L Tris, 10 mmol/L dextran sulfate
                                              buffer, pH 2.5. Peaks assigned comparison standards.

                              Short Hairpin RNA Lentivirus Infection
                                              selectively knock NDST1 forkhead box O3a (FOXO3A) ES cells,                                               infected cells using short hairpin RNAs (shRNAs) complementary NDST1, FOXO3A,                                               green fluorescent protein (GFP; gift Nir Hacohen, Center Immunology &
                                              Inflammatory Diseases, Massachusetts General Hospital, Boston, Mass). shRNA 

                                                   Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                            Page 4


                                              inserted replication-deficient lentiviruses possess puromycin-resistant gene,                                               allows selection infected cells. Briefly, 24-hour-old embryoid bodies infected
                                              viruses 1 5 multiplicities infection presence polybrene transfection
NIH-PA Author Manuscript




                                              reagent overnight. Fresh medium replenished 3 days. RNA harvested                                               specific time points infection subjected RT-PCR, described online                                               Data Supplement.

                              Zebrafish Studies
                                              Zebrafish [TÃ¼bingenAB tg(Fli:eGFP)] embryos maintained standard E3 solution
                                              buffered HEPES 2 mmol/L. splice donor morpholino used inhibit                                               expression zebrafish NDST1. morpholino sequence based 8 overlapping
                                              3â€²-exons 3 predicted open reading frames, >50  identity human NDST1                                               zebrafish genome assembly (Zv6 Sanger Institute Ensemble, Cambridge, United
                                              Kingdom; GenBank accession numbers XP_699032, XP_695253, XP_691043).                                               exon-3 splice donor morpholino predicted lead splicing exon 2 exon 4.
                                              Scrambled morpholinos used control. Increasing concentrations morpholinos
                                              injected 2-cell-stage embryos constant volume 4.6 nL Nanoject II
                                              (Drummond Scientific, Broomall, Pa). test patency vessels, 4.6 nL 10 
NIH-PA Author Manuscript




                                              tetramethylrhodamine-labeled 40-kDa dextran (Molecular Probes, Carlsbad, Calif)                                               injected cardiac venous sinus. Bright-field fluorescence images embryos
                                              captured Nikon SMZ1500 stereomicroscope SPOT Flex camera
                                              (Diagnostic Instruments,  Sterling Heights, Mich). Image sequences obtained                                               setup exported movies match live flow patterns. procedures                                               approved Harvard University's Institutional Animal Care Use Committee.

                              Affymetrix Oligonucleotide Gene Arrays
                                              Embryos injected NDST1 morpholino wild-type siblings harvested                                               6- 20-somite developmental stages 24 hours fertilization (hpf). Total RNA
                                              extracted TRIzol reagent (Invitrogen, Carlsbad, Calif) purified Qiagen
                                              RNeasy columns (Qiagen, Valencia, Calif). Hybridization Affymetrix zebrafish genome
                                              arrays data acquisition performed Harvard Medical School Partners
                                              Healthcare Center Genetics Genomics. Quality control GeneChip
                                              Operating Software (GCOS; Affymetrix, Santa Clara, Calif) DNA-Chip Analyzer
NIH-PA Author Manuscript




                                              (dChip).11a Acquired probe-level data normalized robust multichip average
                                              method, mean log 2 expression intensities triplicate experiments used                                               subsequent differential analysis. Local pooled error ANOVA differential expression
                                              testing performed S-Plus (Tibco Software, Palo Alto, Calif), P<0.05                                               Bonferroni Benjamini-Hochberg corrections applied define significant genes                                               limit false-positive results, respectively. Regulated transcripts investigated use
                                              modified t test, R version Cyber-T algorithm. Gene pathways based                                               transcripts regulated robust multichip average method MAS5 data                                               3 time points Cyber-T fold-change criteria described defined                                               Cell Illustrator software Ingenuity Pathways Analysis (Ingenuity Systems, 
                                              Redwood City, Calif). Independent component analysis performed MATLAB
                                              software  MathWorks, Natick, Mass; online Data Supplement). Affymetrix


                                                    Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                            Page 5


                                              probe sets annotated basis gene symbols available Affymetrix
                                              Netaffix World Wide Web site, Entrez Gene, Unigene, GenBank, Boston Trans-NIH
                                              Zebrafish Genome Initiative. Undefined transcripts identified Affymetrix probe IDs.
NIH-PA Author Manuscript




                                              subset differential transcript abundance confirmed RT-PCR.

                              Statistical Analysis
                                              results expressed meanÂ±SEM triplicate samples. Statistical
                                              comparisons obtained 1-way ANOVA followed Newman-Keuls post hoc test.
                                              Tests performed PRISM software (GraphPad Software, San Diego, Calif).
                                              Statistical comparisons 2 groups obtained Student t test. P<0.05                                               considered significant.


                              Results
                              ES Cells Differentiate Endothelial Cells
                                              present study, selected characterized embryonic stem cellâ€“embryoid body
                                              (ESC-EB), closely mimics vivo maturation process, vitro model                                               study vasculogenesis. grown ultralow adherent conditions absence NIH-PA Author Manuscript




                                              leukemia inhibitory factor, ES cells start forming solid morula-like structures 2 days,
                                              progressively increase size finally cavitated (Figure 1B). shown                                               Figure 1A, expression levels endothelial cell markers VE-cadherin, VEGFR2
                                              (vascular endothelial growth factor receptor-2), von Willebrand factor, Tie-2,                                               angiopoietin-2 increased, expression stem cell marker Oct 4 decreased
                                              progressively 10-day period, consistent differentiation vascular
                                              endothelial cells. Confocal imaging immunolabeling ESCEBs von
                                              Willebrand factor revealed negligible signal day 3 progressively increased time
                                              (Figure 1B). findings consistent previous reports12 increase                                               endothelial cell markers observed day 3 differentiation. Hemangioblast
                                              precursors established time point, coincides onset                                               vasculogenesis mouse embryo.13

                              HSGAG Synthesis Upregulated ES Cell Differentiation
                                              Differentiation ES cells endothelial cells paralleled increase NDST1
NIH-PA Author Manuscript




                                              transcripts protein, key regulator sulfation modification nascent
                                              HSGAG chain (Figure 1C 1D).14 investigate functional implication NDST1
                                              expression, analyzed compositional changes cell-surface HSGAG ESC-EB
                                              differentiation using reverse-polarity capillary electrophoresis. Interestingly,                                               increase higher-order sulfated HSGAGs fragments ESC-EB differentiation
                                              (Figure 1E), indicates involvement glycocalyx vasculogenic process.

                              HSGAGs Modulate Differentiation ES Cells Endothelial Cells
                                              HSGAGs biopolymers disaccharide units uronic acid glucosamine                                               sulfated 3 residues (Figure 2A). Treatment sodium chlorate indirectly blocks                                               sulfation HSGAG competitively inhibiting formation 3â€²-phosphoadenosine-5â€²-
                                              phosphosulfate, high-energy sulfate donor cellular sulfation reactions.15 shown 

                                                    Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                             Page 6


                                              Figure 2B, capillary electrophoresis cell-surface HSGAGs demonstrates absence                                               sulfated disaccharide peaks 7 days treatment sodium chlorate compared                                               untreated control cells. inhibition paralleled concentration-dependent decrease
NIH-PA Author Manuscript




                                              protein expression endothelial cell marker von Willebrand factor (Figure 2C).
                                              Interestingly, expression endothelial cell marker restored                                               addition exogenous heparin (Figure 2D), establishes causal link                                               HSGAGs endothelium formation novo. validated treatment                                               differentiating cells heparinase III, digest HSGAGs regions                                               high low sulfation, respectively,16 resulted significant downregulation                                               endothelial cell markers (Figure 2E 2H; online Data Supplement Figure .                                               confirm role HSGAGS ES differentiation endothelial cells, knocked
                                              HSGAG-modifying enzyme NDST1 ES cells using NDST1 shRNA. shown
                                              Figure 2I, resulted 80  knockdown NDST1, translated significant
                                              reduction endothelial markers Tie-2, von Willebrand factor, angiopoietin-2,
                                              directly implicating NDST1 differentiation ES cells endothelial lineage.

                              Suppression NDST1 Leads Aberrant Vasculature Formation Zebrafish Embryo
                                              validate present vitro results vivo  adopted strategy NIH-PA Author Manuscript




                                              genetically manipulated HSGAG synthesis zebrafish embryos. BLAST (Basic Local
                                              Alignment Search Tool) analysis revealed zebrafish ortholog NDST1 chromosome
                                              21 (Figure 3I). Given variety predicted ATG initiation sites locus, splice donor
                                              morpholino designed exon shared 3â€²-end exons common 3
                                              predicted transcripts. confirm effectiveness morpholino, designed specific
                                              primers RT-PCR RNA prepared injected control 72-hpf embryos.
                                              Sequencing subcloned fragments confirmed altered splicing resulted                                               premature stop codon. confirm morpholino resulted attenuation                                               HSGAG sulfation, harvested cell-surface HSGAGs 24-hpf embryos                                               subjected compositional analysis using capillary electrophoresis. shown                                               Figure 3 (II), NDST1 knockdown resulted significant reduction sulfated
                                              disaccharides.

                                              seen Figure 3 (III), morpholino-induced knockdown NDST1 resulted                                               concentration-dependent aberrant formation dorsal aorta, caudal vein, intersegmental
NIH-PA Author Manuscript




                                              vessels, contributed shortened, dysmorphic tails. higher
                                              concentrations morpholino resulted complete ablation blood flow                                               cloacae resulted dysmorphic tails, lower concentrations produced proximal
                                              confluence dorsal aorta posterior cardinal vein. lower concentrations
                                              induced vascular abnormalities, shortening tail observed, suggests                                               dysmorphic tail secondary result primary abnormal vascularization.                                               cases, stagnant blood cells space usually occupied caudal vein
                                              plexus moved synchronously heartbeat (Figure 3 [IIIB]; online Data
                                              Supplement Movie . findings consistent TÃ¼bingenAB                                               tg(Fli:GFP) embryos. Decreased vascular blood flow zNDST1 embryos associated
                                              smaller vessel lumen, evident injection 40 kDa tetramethylrhodamine-
                                              labeled dextran.


                                                    Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                                Page 7


                              Exogenous Sulfated HSGAGs Rescues Impaired Vascular Phenotype
                                              test exogenous sulfated HSGAGs induce recovery vascular phenotype, NIH-PA Author Manuscript




                                              treated NDST1 knockdown cells heparin, highly sulfated HSGAG analog.
                                              shown Figure 4, treatment heparin increased endothelium-specific transcripts.
                                              Furthermore, heparin induced partial recovery phenotype NDST1-knockdown
                                              zebrafish (Figure 4B).

                              Glycocalyx Modifications Modulate Transcriptome Signatures Developing Zebrafish
                              Embryo
                                              elucidate glycocalyx-mediated effects transcriptome regulators vasculogenesis,                                               performed global gene-expression analysis zNDST1 morphants wild-type siblings                                               6-somite, 20-somite, 24-hpf time points, correspond significant stages                                               zebrafish vessel development (migration angioblasts midline, major lateral vessel
                                              formation, intersegmental angiogenesis).17 local pooled error method used                                               identify differentially expressed transcripts zNDST1 mutants wild-type siblings
                                              3 developmental stages, revealed 218 significant transcripts (corrected P value
                                              <0.05, fold-change <0.75 >1.25; online Data Supplement Table . Hierarchal
NIH-PA Author Manuscript




                                              clustering Euclidean distance metric demonstrated distinct temporal expression
                                              patterns 50 transcripts (Figure 5A). Independent component analysis confirmed
                                              local pooled error analysis, 93  transcripts identified                                               differentially expressed local pooled error analysis 0.5                                                transcripts contributed NDST1-associated ICA component 2 (Figure 5B).                                               Independent Component Analysis component 2 additionally identified 34 genes
                                              associated NDST knockdown (online Data Supplement Table V). ANOVA
                                              analysis MAS5-normalized data used define significant changes gene
                                              transcription comparison developmental stages (Benjamini-Hochberg corrected P
                                              value <0.05; online Data Supplement Table II). Notably, greater number                                               significant transcripts 20-somite stage (619) 6-somite stage
                                              (67) 24 hpf (119), shown Figure 5C. Regulated genes significant cell
                                              signaling, transcription factors, cell proliferation/differentiation, protein stability, apoptosis,
                                              matrix interactions highlighted Figure 5D. Finally, data log base 2
                                              transformed, normalized MAS5 robust multichip average methods,                                               analyzed Cyber-T (Pâ‰¤0.05, mean fold-change â‰¤2 NDST1 morphant NIH-PA Author Manuscript




                                              wild type; online Data Supplement Tables III IV). ANOVA method,
                                              analysis, 20-somite stage differentially regulated transcripts,
                                              overlapping transcripts existed different stages (Figure 6A).
                                              Pathway analysis based regulated transcripts developmental stage revealed
                                              interconnected networks regulate apoptosis, differentiation, cell matrix, cell-cell
                                              interaction (Figure 6B 6D).


                              Discussion
                                              present study, focused roles glycosaminoglycan component                                               cell-surface glycome modulating vasculogenesis. step, recapitulated
                                              vasculogen esis ESC-EBs. primary vascular plexus formed embryonic body


                                                    Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                           Page 8


                                              undergoes remodeling day 6 7 onward sprouting angiogenesis.12,13 Interestingly,
                                              comparison compositional analysis cell-surface HSGAGs day 3 day
                                              7 ESC-EB revealed distinct profiles led increase highly sulfated disaccharide
NIH-PA Author Manuscript




                                              residues differentiation. sulfate residues introduced nascent polymer
                                              series sequential enzyme-induced modifications. bifunctional activity                                               NDST family appears key regulator process,                                               modifications,  C5 epimerization 2O, 3O, 6O sulfations, predominate
                                              N-sulfated regions. Interestingly, mRNA transcripts total NDST1
                                              protein levels upregulated vasculogenesis, explain increased
                                              sulfation HSGAG polymer. 4 isoforms NDST distinct tissue
                                              distribution,18 NDST1 NDST2 isoforms expressed vasculature.19
                                              separate study, Johnson et al20 demonstrated similar upregulation NDST4
                                              isoform ESC-EBs directed differentiate neural lineage.                                               observations implicate HSGAG synthetic enzymes differentiation process,                                               indicates postpolymerization modifications introduced nascent chains                                               play critical roles differentiation process specific lineages.

                                              test hypothesis  used morpholino-based approach knock NIH-PA Author Manuscript




                                              expression NDST1 developing zebrafish embryo model, emerged                                               excellent study vasculogenesis transparent embryo allows real-
                                              time functional monitoring evolving vasculature.21 previous study, genetic
                                              perturbation HSGAG synthesis resulted early developmental defects, including
                                              failure differentiate mesodermal precursors endothelium,22,23 prevented
                                              characterization vasculogenesis studies. limitation overcome
                                              zebrafish model, real-time monitoring embryo revealed                                               oligonucleotide-induced knockdown NDST1 resulted reduction HSGAG sulfation,
                                              led abnormal vasculature stunting tail, consistent hypothesis
                                              glycocalyx implicated vasculogenesis. Additionally, shRNA knockdown                                               NDST1 significantly suppressed expression endothelial markers embryoid
                                              bodies. supported fact treatment differentiating embryoid
                                              bodies heparinase III resulted inhibition vasculogenesis. Similarly, sodium
                                              chlorate, prevents sulfation nascent polymer, blocked vasculogenesis.                                               validated partial recovery endothelial phenotype NIH-PA Author Manuscript




                                              embryoid body zNDST1-knockdown zebrafish addition exogenous
                                              heparin, highly sulfated HSGAG analog. results implicate causal link
                                              glycome composition endothelium formation.

                                              previous study, demonstrated cellular pheno-type coregulated                                               cross talk glycome transcriptome.24 Interestingly, Jakobsson et al25
                                              demonstrated HSGAGs expressed perivascular smooth muscle cells support
                                              development capillary structures NDST1/2-/- embryonic stem cells,                                               suggests just endothelial cell-surface HSGAGs glycocalyx                                               surrounding cellular architecture exert â€œbystander effectâ€? modulating
                                              vasculogenesis. decided globally knock NDST1 study effect




                                                    Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                             Page 9


                                              transcriptome, developed mechanistic models based differentially
                                              regulated transcripts implicated neovascularization.
NIH-PA Author Manuscript




                                              surprisingly, large number genes differentially regulated                                               involved signal transduction morphogenesis transcription factors                                                online Data Supplement details). example, spleen tyrosine kinase (SYK)                                               upregulated NDST1knockdown embryos. SYK candidate tumor-suppressor gene                                               implicated suppression cyclin D1.26 suppresses cell motility inhibiting
                                              phosphoinositide-3 kinase activity urokinase-type plasminogen activator secretion,
                                              critical neovascularization.27 Interestingly, phosphoinositide-3 kinase                                               negatively regulates FOXO, described  observed downregulation                                               Wnt receptor, Frizzled, NDST1-knockdown embryos, morphogen,
                                              sonic hedgehog (Shh). Previous studies zebrafish revealed vascular defects                                               Shh-mutant embryos.28

                                              Interestingly, despite implication HSGAGs involved vascular endothelial
                                              growth factor, fibroblast growth factor, platelet-derived growth factor signaling                                               angiogenesis,8â€“10 signals directly modulated NDST1
NIH-PA Author Manuscript




                                              knockdown embryos. Instead, transcription factor FOXO5 (zebrafish ortholog FOXO3A)
                                              insulin-like growth factor-2 (IGF2) consistently upregulated 3
                                              time points. elegant study, Potente et al29 demonstrated vivo FOXO3A
                                              deficiency increased vessel formation maturation. dissected pathway                                               embryoid body model. shown Figure 7, observed FOXO3A levels
                                              decreased cells differentiated endothelial cells. Interestingly, shRNA-mediated
                                              knockdown NDST1 increased FOXO3A transcript protein expression,                                               suggests FOXO3A downstream signal glycome modification. Furthermore,
                                              shRNA-mediated knockdown FOXO3A embryoid bodies resulted decreased
                                              IGF2 transcripts, suggests IGF2 modulated FOXO.                                                evidence bidirec tional signaling IGFs FOXO.30 recent study                                               demonstrated self-renewal pluripotent properties ES cells require IGF
                                              signaling.31 contrast, study demonstrated IGF2 implicated homing                                               endothelial progenitor cells.32 indicates regulation IGF activity differentiation
                                              progenitor cells endothelial cells, warrants studies. additional
                                              pathways coordinating glycome-transcriptome cross talk vasculogenesis, NIH-PA Author Manuscript




                                              present results clearly implicate FOXOIGF signaling axis process.

                                              conclusion, clearly demonstrate involvement HSGAGs, key components                                               cell-surface glycome, vasculo-genesis. Furthermore, elucidated                                               critical downstream pathways implicated mediating glycome regulation                                               vasculogenesis. study reveals exciting potential harnessing defined cellular
                                              glycomicroenvironments directed differentiation precursor cells therapeutic
                                              neovascularization.

                                              




                                                    Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                                       Page 10


                              Supplementary Material
                                              Refer Web version PubMed Central supplementary material.
NIH-PA Author Manuscript




                              Acknowledgments
                                              Sources Funding

                                              Dr Sengupta supported Scientist Development Grant American Heart Association                                               Department Defense Breast Cancer Research Program Era Hope Scholar Award. Dr Harfouche supported
                                              Canadian Institutes Health Research postdoctoral fellowship.


                              References
                                              1. Heart disease stroke statisticsâ€”2007 update: report American Heart Association
                                                 Heart Statistics Committee Stroke Statistics Subcommittee. Circulation. 2007; 115:e69â€“e171.
                                                 [PubMed: 17194875]
                                              2. Ferrara N, Kerbel RS. Angiogenesis therapeutic target. Nature. 2005; 438:967â€“974. [PubMed:
                                                 16355214]
                                              3. Risau W. Mechanisms angiogenesis. Nature. 1997; 386:671â€“674. [PubMed: 9109485]
                                              4. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM,
                                                 Itescu S. Neovascularization ischemic myocardium human bone-marrow-derived angioblasts
NIH-PA Author Manuscript




                                                 prevents cardiomyocyte apoptosis, reduces remodeling improves cardiac function. Nat Med.
                                                 2001; 7:430â€“436. [PubMed: 11283669]
                                              5. SchÃ¤chinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ,
                                                 Hofmann WK, Martin H, Dimmeler S, Zeiher  Transplantation progenitor cells                                                  regeneration enhancement acute myocardial infarction: final year results TOPCARE-
                                                 AMI Trial. J Coll Cardiol. 2004; 44:1690â€“1699. [PubMed: 15489105]
                                              6. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, Nakao K,
                                                 Nishikawa S. Flk1-positive cells derived embryonic stem cells serve vascular progenitors.
                                                 Nature. 2000; 408:92â€“96. [PubMed: 11081514]
                                              7. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. Endothelial cells derived human
                                                 embryonic stem cells. Proc Natl Acad Sci U S  2002; 99:4391â€“4396. [PubMed: 11917100]
                                              8. Li  Wu JC, Sheikh AY, Kraft D, Cao F, Xie X, Patel M, Gambhir SS, Robbins RC, Cooke JP, Wu
                                                 JC. Differentiation, survival, function embryonic stem cell derived endothelial cells                                                  ischemic heart disease. Circulation. 2007; 116(suppl) 46 54.
                                              9. Lundin L, Larsson H, Kreuger J, Kanda S, Lindahl U, Salmivirta M, Claesson-Welsh L. Selectively
                                                 desulfated heparin inhibits fibroblast growth factor-induced mitogenicity angiogenesis. J Biol
                                                 Chem. 2000; 275:24653â€“24660. [PubMed: 10816596]
                                              10. Gitay-Goren H, Soker S, Vlodavsky  Neufeld G. binding vascular endothelial growth
NIH-PA Author Manuscript




                                                   factor receptors dependent cell surface-associated heparin-like molecules. J Biol Chem.
                                                   1992; 267:6093â€“6098. [PubMed: 1556117]
                                              11. Abramsson  Kurup S, Busse M, Yamada S, Lindblom P, Schallmeiner E, Stenzel D, Sauvaget D,
                                                   Ledin J, Ringvall M, Landegren U, KjellÃ©n L, Bondjers G, Li JP, Lindahl U, Spillmann D,
                                                   Betsholtz C, Gerhardt H. Defective N-sulfation heparan sulfate proteoglycans limits PDGF-BB
                                                   binding pericyte recruitment vascular development. Genes Dev. 2007; 21:316â€“331.
                                                   [PubMed: 17289920]
                                              11a. Li C, Wong H. Model-based analysis oligonucleotide arrays: expression index computation                                                      outlier detection. Proc Natl Acad Sci. 2001; 98:31â€“36. [PubMed: 11134512]
                                              12. Evans AL, Bryant J, Skepper J, Smith SK, Print CG, Charnock-Jones DS. Vascular development                                                    embryoid bodies: quantification transgenic intervention antiangiogenic treatment.
                                                   Angiogenesis. 2007; 10:217â€“226. [PubMed: 17577673]
                                              13. Nakagami H, Nakagawa N, Takeya Y, Kashiwagi K, Ishida C, Hayashi S, Aoki M, Matsumoto K,
                                                   Nakamura T, Ogihara T, Morishita R. Model vasculogenesis embryonic stem cells 


                                                    Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                                  Page 11


                                                  vascular research regenerative medicine. Hypertension. 2006; 48:112â€“119. [PubMed:
                                                  16754788]
                                              14. Grobe K, Ledin J, Ringvall M, Holmborn K, Forsberg E, Esko JD, KjellÃ©n L. Heparan sulfate NIH-PA Author Manuscript




                                                  development: differential roles N-acetylglucosamine N-deacetylase/N-sulfotransferase
                                                  isozymes. Biochim Biophys Acta. 2002; 1573:209â€“215. [PubMed: 12417402]
                                              15. Delehedde M, Seve M, Sergeant N, Wartelle  Lyon M, Rudland PS, Fernig DG. Fibroblast
                                                  growth factor-2 stimulation p42/44MAPK phosphorylation IkappaB degradation                                                   regulated heparan sulfate/heparin rat mammary fibroblasts. J Biol Chem. 2000; 275:33905â€“
                                                  33910. [PubMed: 10944532]
                                              16. Ernst S, Langer R, Cooney CL, Sasisekharan R. Enzymatic degradation glycosaminoglycans.
                                                  Crit Rev Biochem Mol Biol. 1995; 30:387â€“444. [PubMed: 8575190]
                                              17. Jin SW, Beis D, Mitchell T, Chen JN, Stainier DY. Cellular molecular analyses vascular
                                                  tube lumen formation zebrafish. Development. 2005; 132:5199â€“5209. [PubMed: 16251212]
                                              18. Iozzo RV. Basement membrane proteoglycans: cellar ceiling. Nat Rev Mol Cell Biol.
                                                  2005; 6:646â€“656. [PubMed: 16064139]
                                              19. Esko JD, Selleck SB. Order chaos: assembly ligand binding sites heparan sulfate. Annu
                                                  Rev Biochem. 2002; 71:435â€“471. [PubMed: 12045103]
                                              20. Johnson CE, Crawford  Stavridis M, Dam G, Wat AL, Rushton G, Ward CM, Wilson V,
                                                  van Kuppevelt TH, Esko JD, Smith  Gallagher JT, Merry CL. Essential alterations heparan
                                                  sulfate differentiation embryonic stem cells Sox1-enhanced green fluorescent
                                                  protein-expressing neural progenitor cells. Stem Cells. 2007; 25:1913â€“1923. [PubMed: 17464092]
NIH-PA Author Manuscript




                                              21. Kidd KR, Weinstein BM. Fishing novel angiogenic therapies. Br J Pharmacol. 2003; 140:585â€“
                                                  594. [PubMed: 14534143]
                                              22. Lin X, Wei G, Shi  Dryer L, Esko JD, Wells  Matzuk MM. Disruption gastrulation                                                   heparin sulfate biosynthesis EXT1-deficient mice. Dev Biol. 2000; 224:299â€“311. [PubMed:
                                                  10926768]
                                              23. Stickens D, Zak BM, Rougier N, Esko JD, Werb  Mice deficient Ext2 lack heparan sulfate                                                   develop exotoses. Development. 2005; 132:5055â€“5068. [PubMed: 16236767]
                                              24. Johnson NA, Sengupta S, Saidi SA, Lessan K, Charnock-Jones SD, Scott L, Stephens R, Freeman
                                                  TC, Tom BD, Harris M, Denyer G, Sundaram M, Sasisekharan R, Smith SK, Print CG.
                                                  Endothelial cells preparing die apoptosis initiate program transcriptome glycome
                                                  regulation. FASEB J. 2004; 18:188â€“190. [PubMed: 14630703]
                                              25. Jakobsson Kreuger J, Holmborn K, Lundin L, Eriksson  KjellÃ©n L, Claesson-Welsh L. Heparan
                                                  sulfate trans potentiates VEGFR-mediated angiogenesis. Dev Cell. 2006; 10:625â€“634.
                                                  [PubMed: 16678777]
                                              26. Wang L, Devarajan E, J, Reddy SP, Dai JL. Transcription repressor activity spleen tyrosine
                                                  kinase mediates breast tumor suppression. Cancer Res. 2005; 65:10289â€“10297. [PubMed:
                                                  16288017]
                                              27. Mahabeleshwar GH, Kundu GC. SYK, protein tyrosine kinase, suppresses cell motility                                                   nuclear factor kappa B-mediated secretion urokinase type plasminogen activator inhibiting
NIH-PA Author Manuscript




                                                  phosphatidylinositol 3â€²-kinase activity breast cancer cells. J Biol Chem. 2003; 278:6209â€“
                                                  6221. [PubMed: 12477728]
                                              28. Chen JN, Haffter P, Odenthal J, Vogelsang E, Brand M, van Eeden FJ, Furutani-Seiki M, Granato
                                                  M, Hammerschmidt M, Heisenberg CP, Jiang YJ, Kane DA, Kelsh RN, Mullins MC, NÃ¼sslein-
                                                  Volhard C. Mutations affecting cardiovascular internal organs zebrafish.
                                                  Development. 1996; 123:293â€“302. [PubMed: 9007249]
                                              29. Potente M, Urbich C, Sasaki K, Hofmann WK, Heeschen C, Aicher  Kollipara R, DePinho RA,
                                                  Zeiher  Dimmeler S. Involvement Foxo transcription factors angiogenesis postnatal
                                                  neovascularization. J Clin Invest. 2005; 115:2382â€“2392. [PubMed: 16100571]
                                              30. Liu TJ, Lai HC, Ting CT, Wang PH. Bidirectional regulation upstream IGF insulin receptor
                                                  signaling downstream FOXO1 cardiomyocytes. J Endocrinol. 2007; 192:149â€“158.
                                                  [PubMed: 17210752]
                                              31. Bendall SC, Stewart MH, Menendez P, George D, Vijayaragavan K, Werbowetski-Ogilvie T,
                                                  Ramos-Mejia V, Rouleau  Yang J, BossÃ© M, Lajoie G, Bhatia M. IGF FGF cooperatively


                                                    Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                             Page 12


                                                  establish regulatory stem cell niche pluripotent human cells vitro. Nature. 2007;
                                                  448:1015â€“1021. [PubMed: 17625568]
                                              32. Maeng Y, Choi H, Kwon J, Park YW, Choi KS, Min JK, Kim YH, Suh PG, Kang KS, Won MH,
NIH-PA Author Manuscript




                                                  Kim YM, Kwon YG. Endothelial progenitor cell homing: prominent role IGF2-IGF2R-
                                                  PLCbeta2 axis. Blood. 2009; 113:233â€“243. [PubMed: 18832656]
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                    Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                          Page 13



                                                                                CLINICAL PERSPECTIVE
                                              Promotion neovasculature holds potential ameliorating coronary artery disease.
NIH-PA Author Manuscript




                                              TOPCARE-AMI (Transplantation Progenitor Cells Regeneration
                                              Enhancement Acute Myocardial Infarction) trial indicated circulating endothelial
                                              progenitor cells improve left ventricular ejection fraction patients                                               myocardial infarction. Recent studies demonstrated embryonic stem cells                                               differentiate functional endothelial cells vasculogenesis, results                                               functional improvement arises increased neovascularization. harnessing                                               vasculogenesis potential revolutionize regenerative medicine contingent
                                              means regulate cellular differentiation. present study, demonstrate                                               glyco-microenvironment stem cell, specifically sulfated heparan sulfate
                                              glycosaminoglycans, plays critical role facilitating vasculogenesis. confirmed
                                              findings vivo larval zebrafish, desulfation heparan sulfate
                                              glycosaminoglycans resulted impaired vascular development. phenotype                                               rescued exogenous sulfated heparan sulfate glycosaminoglycans. Finally,                                               identified downstream pathways mediate regulation                                               vasculogenesis heparan sulfate glycosaminoglycans, including novel FOXO3A/5-
NIH-PA Author Manuscript




                                              IGF2 signaling pathway. study reveals exciting potential harnessing defined
                                              cellular glyco-microenvironments directed differentiation precursor cells                                               endothelial cells, leading neovascularization.
NIH-PA Author Manuscript




                                                    Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                        Page 14
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                                                             Figure 1.
                               Differentiation ES cells endothelium.  vi, Quantification endothelial cell transcripts (VE-cadherin, vascular
                           endothelial growth factor receptor 2 [VEGFR2], von Willebrand factor [vWF], Tie-2, angiopoietin-2 [Ang2]) stem cell
                             marker Oct 4 RT-PCR. B, Bright-field confocal images embryoid bodies stained vWF confirm differentiation
NIH-PA Author Manuscript




                                endothelial lineage. Images captured LSM510 confocal microscope 488-nm wavelength                             excitation emission 516 nm. Inset  ii) represents isotype control immunohistochemistry primary antibody
                           control. PI indicates propidium iodide. C, RT-PCR analysis revealed expression NDST1 differentiation. D, Western
                            blot shows expression NDST1 protein time differentiating embryoid body. E, Compositional analysis HSGAGs
                            capillary electrophoresis heparinase digestion revealed negligible sulfated disaccharides day 3 compared day 7,
                                   vascular precursors established. data expressed grades intensity signal                              electropherogram. Tri-S indicates trisaccharide; Di-S, disaccharide; Mono-S, monosaccharide; Rn, normalized reporter.
                                                                     ***P<0.001 compared day 3 control cells.




                                                  Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                          Page 15
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                                                              Figure 2.
                           Pharmacological modulation HSGAGs regulates vasculogenesis.  Typical disaccharide building block HSGAG polymer
                             comprises uronic acid glucosamine. sulfated residue X sulfated acetylated Y. B, Treatment ES
                           cells sodium chlorate (Sod. chlorate) inhibited sulfation nascent chain, seen capillary electrophoresis. Data                               expressed grades intensity signal electropherogram. ND indicates nondetectable; Tri-S, trisaccharide; Di-S,
                              disaccharide; Mono-S, monosaccharide. C, Fluorescence-activated cell sorter analysis expression von Willebrand
                             factor (vWF) sodium chlorateâ€“treated embryoid bodies showed concentration-dependent inhibition vasculogenesis (D)
                            reversed exogenous heparin. Eâ€“H, Differentiation ES cells endothelial cells inhibited treatment
                               heparinase III sodium chlorate quantified monitoring level transcripts endothelial cell markers
                             (vascular endothelial growth factor receptor 2 [VEGFR2], angiopoietin 2 [Ang2], Tie-2, vWF) RT-PCR. **P<0.05,
                             **P<0.01, ***P<0.001 compared control. #P<0.01 vs day 3.  NDST1 gene knocked ESC-EBs 7 days
                                NDST1 shRNA (gray bars), gene expression NDST1 endothelial markers (Tie-2, vWF, Ang2)                            quantified RT-PCR. GFP shRNA served internal control (black bars). *P<0.05 compared GFP-shRNA. Veh indicates
                                                                 vehicle; Rn, normalized reporter; Hep., heparinase.
NIH-PA Author Manuscript




                                                   Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                     Page 16
NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                                                             Figure 3.
                               Morpholino-induced knockdown NDST1 impairs vasculogenesis zebrafish embryo.  BLAST analysis revealed 3
                           zebrafish orthologs zNDST1 chromosome 21 60  sequence identity mouse NDST (mNDST). B, morpholino
                           (GTGCATTTAACACTCACCATTCTTC) designed block splice donor site exon 3 (Ex3 Mo). WT indicates wild
                                type. C, RT-PCR confirmed effectiveness morpholino dose-dependent manner. Sequencing subcloned
                            fragments confirmed altered splicing resulted premature STOP codon. II, Capillary electrophoresis HSGAG profile
                               wild-type NDST1 knockdown (NDST1-kd) zebrafish 24 hpf revealed absence sulfated disaccharides                            NDST1 knockdown compared wild type. Data expressed grades intensity signal electropherogram.


                                                  Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                     Page 17


                           Tri-S indicates trisaccharide; Di-S, disaccharide; Mono-S, monosaccharide; ND, nondetectable. III  Morpholino-injected
                            tg(Fli1;GFP) fish displayed decreased intersegmental vessels dysmorphic tails dose-dependent manner. III-B, Bright-
                             field images TÃ¼bingenAB 48-hpf WT fish   1.15-pmol morpholinoâ€“injected fish. Blood cells accumulated NIH-PA Author Manuscript




                            caudal vein plexus morpholino-injected embryos. III-C,  54-hpf tg(Fli:GFP) embryos injected low-dose zNDST1
                           morpholino displayed weaker density tail intersegmental vessels.  40-kDa tetramethylrhodamine (TMR) injected                                                     WT knockdown fish revealed smaller lumens zNDST-injected embryos.
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                 Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                      Page 18
NIH-PA Author Manuscript




                                                                                            Figure 4.
                             Exogenous heparin rescues NDST1-knockdown (NDST1-kd) phenotype.  RT-PCR data showing transcript levels                             endothelial cell markers, Tie-2 VEGFR2 (vascular endothelial growth factor receptor 2), differentiating ES cells                             shRNA-induced NDST1 knockdown. Incubation heparin (20 Î¼g/mL) induced recovery transcript levels NDST1
                           knockdown. Data meanÂ±SE (n=3). B, Injection heparin zNDST1 morpholino-treated zebrafish resulted partial
NIH-PA Author Manuscript




                            recovery tail phenotype, used reporter vascularization defects. Graph shows mean tail lengths Â±SE 7 8
                                                       fish treatment group. *P<0.05, **P<0.01, ***P<0.001 vs controls.
NIH-PA Author Manuscript




                                                 Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                            Page 19
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                                                              Figure 5.
                            Temporal transcriptome analysis wild-type (WT) vs NDST1 knockdown zebrafish.  Heat map created 50
                           significant transcripts according local pooled error testing S-Plus software. Differential expression trends clearly visible
                                 WT morphant zebrafish embryos 6-somite, 20-somite, 24-hpf developmental stages. Unidentified
                            transcripts denoted Affymetrix identification numbers. B, Hinton plot created independent component analysis
                                  robust multichip average (RMA) methodâ€“normalized expression levels reveal gene signatures method                            independent parametric statistics. Columns represent chips; rows represent latent gene signatures. Colors sizes squares
NIH-PA Author Manuscript




                               represent direction (positive negative) degree component represented chip. Components
                               specific knockdown, developmental stage, individual biological replicates arrowed. Ninety percent                                 transcripts identified differentially expressed local pooled error analysis 0.5  transcripts                                 contributed independent component analysis component 2, separated WT NDST1 knockdown. C, ANOVA
                           analysis (P<0.05) S-Plus revealed 67, 619, 119 regulated transcripts WT morphant RNA 6-somite, 20-
                              somite, 24 hpf stages, respectively. 34 transcripts overlapped developmental stages highlighted                            Venn diagram. Inset shows confirmation zebrafish FOXO5 IGF2 expression quantitative PCR. D, Cartoon classifying
                              transcripts modulated WT NDST1 implicated neovascularization. 6S indicates 6 somite;
                                                                          20S, 20 somite; Rn, normalized reporter.




                                                   Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                        Page 20
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                                                             Figure 6.
                             Pathways implicated glycocalyx regulation vasculogenesis.  time point, scatterplots compare mean transcript
                            abundance 3 wild-type replicates (x axis) 3 zNDST1 morphant replicates (y axis). transcripts                            Pâ‰¥0.01 fold-change â‰¤2 Cyber-T analysis 24-hpf time point highlighted green 3 time points. B, C,                             D, Cell Illustrator Ingenuity pathway analyses used construct pathways significantly regulated transcripts                            6-somite (6S), 20-somite (20S), 24-hpf developmental stages according Cyber-T analysis. right-tailed Fisher exact test
                           indicated likelihood pathways constituted random samples 67, 619, 119 transcripts drawn
                                                                      Affymetrix microarrays â‰¥0.05.
NIH-PA Author Manuscript




                                                  Circulation. Author manuscript; available PMC 2014 April 28.
                           Harfouche et al.                                                                                       Page 21
NIH-PA Author Manuscript




                                                                                             Figure 7.
                               FOXO3A IGF signaling NDST1-mediated vasculogenesis.  Graph shows expression FOXO3A transcripts                             differentiating embryoid bodies function time. B, Transcript levels FOXO3A GFP- NDST1-shRNAâ€“treated
                                cells quantified RT-PCR. C, Western blot showing levels FOXO3A proteins control   NDST1
                              knockdown ES cells. D, Graph shows transcript levels IGF2 NDST1 knockdown ES cells. E, shRNA-mediated
                           knockdown FOXO3A resulted downregulation IGF2, indicated IGF2 downstream FOXO3A. shRNA
NIH-PA Author Manuscript




                           GFP used control. Data shown meanÂ±SE 3 independent experiments. **P<0.01, ***P<0.001 vs
                           